Sunny Pharmtech Inc. (TPEX:6676)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
15.85
+0.05 (0.32%)
Mar 10, 2026, 1:00 PM CST
-20.95%
Market Cap 2.35B
Revenue (ttm) 290.18M
Net Income (ttm) -269.51M
Shares Out 148.82M
EPS (ttm) -1.82
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 198,603
Average Volume 319,185
Open 15.80
Previous Close 15.80
Day's Range 15.35 - 16.55
52-Week Range 12.90 - 20.60
Beta 0.09
RSI 46.66
Earnings Date Apr 17, 2026

About Sunny Pharmtech

Sunny Pharmtech Inc. engages in the research, development, and sale of new and generic drug in Taiwan, the United States, and internationally. Its products portfolio include lidocaine ointment that can be used as an anesthetic lubricant for intubation, which temporarily relieves pain associated with minor burns, sunburn, skin abrasions, and insect bites; cyanocobalamin injection for use in vitamin B12 deficiency and pernicious anemia caused by malabsorption; nitrofurantoin capsules for urinary tract infection; aminocaproic acid tablets for bloo... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 158
Stock Exchange Taipei Exchange
Ticker Symbol 6676
Full Company Profile

Financial Performance

In 2024, Sunny Pharmtech's revenue was 418.01 million, a decrease of -2.52% compared to the previous year's 428.83 million. Losses were -156.00 million, 146.4% more than in 2023.

Financial Statements

News

There is no news available yet.